Prot# D5130C05262: A Randomized, Double-Blind, Parallel Group, Phase 3, Efficacy and Safety Study of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO - A Stud

Project: Research project

StatusFinished
Effective start/end date8/28/088/28/11

Funding

  • AstraZeneca Pharmaceuticals LP (D5130C05262 PLATO)